TheUS Vice President-Value and Access is a key member of Pierre Fabre Pharmaceuticals Inc. leadership team.Reportingdirectly to theChiefCommercialOfficer, the incumbentis responsible forsecuringand enabling patient access to our portfolio of products across all payer and relevant distribution channels, while maximizing value to PFPIncumbent will develop and support the execution of strategies for securing pricing, coverage, and reimbursementfor company portfolioThe VP of Value and Access’ primarypriorityis to support the successfullaunchand commercialization ofcelltherapy (tabelecleucel) and future rare diseasetherapiesfrom the value and access standpoint.The VP of Value and access will be focused on delivering accessto innovativesolutions for complex patients suffering from a devastating rare disease, Epstein-Barr Virus Positive Post Transplant Lymphoproliferative Disease (EBV+ PTLD). Patients with a history of bone marrow or solid organ transplant can suffer from this rare, often deadly lymphoma, which currently has no approved FDA therapies.

Activities conducted by theVice President – Value andAccess will includebut are not limited to direct leadership of dynamicteam of V&A Access professionals, development of payer value proposition, reimbursement strategy, HEOR strategy,distributionand trade policy.Incumbentwill be accountable forestablishingmetrics tomonitorpatient access and for refining strategies and programs accordingly tooptimizeaccess and enable commercial success.

Given the complexities of cell therapy, this role will play a critical part in addressingsiteof care dynamics, centers of excellence networks,single caseagreements, and distribution network expansion to enable broad access across both academic and community centers.This role requires a thorough understanding of the complexities of the US Healthcare system as related to advanced therapies, orphan drugs and across sites of care (inpatient/ outpatient).

Thisleaderwill work in close collaboration with multiple internal partners such as Patient Affairs, Medical Affairs,Regulatory Affairs,Global Value & Access organization,marketing, Technical Operations, Clinical Development, Global Value &Accessand external stakeholders.

ESSENTIAL FUNCTIONS:

• The role will include direct leadership of anexisting, smallValue & Access teamwith the goalto buildout a best-in-class organization and capability

• Hiringand performance management of VA team

• Act astheorganizational expert on government pricing andaccountable for setting theoverallaccesspricing strategy for Tab-Cel

• Accountable forthe development,management,and tracking ofobjectivesand budgets. Supports the businessobjectivesofTab-Cel commercialization,patient access,reimbursement, and health systems strategyinsights

• The incumbent will have ultimate accountability for evidence development/dissemination strategies and execution of US value access strategies

• Enablesvalue &access and commercial success by reflecting the needs of non-clinical stakeholders into lifecycle evidence of value andvalue &access strategies for business unit

• Successfulcandidatewill work closely with multiple cross-functional partners across the Pierre Fabre Pharmaceutical organization including global partners

• Strong emotional intelligence and self-awareness supporting outstanding people and organizational leadership capabilities

• Highly collaborative, team player, prioritizing organizationaloutcomesvs functional self interest

• Evolve and develop PFP Value and Access function capabilities and support of individual Value and Access team members professional development

• High learning agility, flexibility of style, willing to take balanced risks and adopt innovative approaches

• Highly driven,good workethic, candid communicatorwho quickly buildstrusting, productive relationships

REQUIRED EDUCATION AND EXPERIENCE:

• Bachelor’s degree in business, marketing, life sciences, or related discipline

• Minimum8+ years of experience inValueAccess(Market Access)+ HEORincluding 3-5 years of leadership experience

• Critical experience includes pricing and contracting strategies for medical and pharmacy benefit products

• Successfultrack recordof developing and executing against launch plan/long range plans

• Demonstratedexperience in Cellor gene therapy

• Proven formal leadership experience leading and developingand scalingkey talent highly preferred

• Deep knowledge of US Medicare, commercial and Federal payers,complexreimbursement methodologies and perspectives, and current health policy trends

• Deep knowledge of global evidence requirements thatimpactreimbursement and market access

• High capacity to work collaboratively across multiple functional areas at varying levels of the organization

PREFERRED EDUCATION AND EXPERIENCE:

• Advanced degree in health economics or outcomes research or healthcare related field preferred

• Rare disease or oncology experience

• Enterprise mind set

• Experience inoncologyacademic and community marketplace for Part B products